LoadingLoadingLoading35 funds hold it.Insiders net selling.
Net selling: insiders sold $5.9M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $16K to $65K in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Sep 1, 2026
Financial period
Q1 FY2027
Earnings per share
$1.39 expected
Revenue
$9.54B expected
Estimates as of Nov 7, 2026
EPS expected
$1.32 to $1.34
Revenue expected
24 analysts
Last 30 days
Split both ways
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Jul 31, 2026Reported Sep 1, 2026 | $1.45est. $1.39 | +4.51%beat | $9.76Best. $9.54B+2.21% | +13.7%from $8.58B |
| Apr 30, 2026Reported Jun 3, 2026 | $1.55est. $1.54 | +0.56%in line | $9.81BCompany release | +9.9%from $8.93B |
| Jan 31, 2026Reported Feb 17, 2026 | $1.36est. $1.34 | +1.86%beat | $9.02BAlpha Vantage | +8.8%from $8.29B |
| Oct 31, 2025Reported Nov 18, 2025 | $1.36est. $1.31 | +3.49%beat | $8.96BAlpha Vantage | +6.6%from $8.40B |
| Jul 31, 2025Reported Aug 19, 2025 | $1.26est. $1.23 | +2.44%beat | $8.58BAlpha Vantage | +8.4%from $7.92B |
| Apr 30, 2025Reported May 21, 2025 | $1.62est. $1.58 | +2.53%beat | $8.93BAlpha Vantage | +3.9%from $8.59B |
| Jan 31, 2025Reported Feb 18, 2025 | $1.39est. $1.36 | +2.21%beat | $8.29BAlpha Vantage | +2.5%from $8.09B |
| Oct 31, 2024Reported Nov 19, 2024 | $1.26est. $1.25 | +0.80%in line | $8.40BAlpha Vantage | +5.2%from $7.98B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $8.96B | $9.02B | $9.81B | $9.76B |
| Cost of what it sold | $3.56B | $3.17B | $2.37B | $3.42B |
| Gross profit | $5.41B | $5.85B | $7.44B | $6.34B |
| What it spent | ||||
| Research and development | $754.0M | $722.0M | $671.0M | $771.0M |
| Sales and admin | $2.96B | $2.92B | $3.06B | $3.20B |
| Other operating costs | — | $441.0M | $2.15B | $607.0M |
| Total operating expenses | $3.72B | $4.08B | $5.88B | $4.58B |
| What was left | ||||
| Operating profit | $1.69B | $1.77B | $1.56B | $1.76B |
| Interest on debt | $181.0M | $181.0M | $177.0M | $186.0M |
| Profit before tax | $1.60B | $1.40B | $1.83B | $1.77B |
| Tax | $215.0M | $254.0M | $575.0M | $289.0M |
| Net profit | $1.37B | $1.14B | $1.24B | $1.47B |
| EBITDA | $2.52B | $2.33B | $2.64B | $2.68B |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
S&P revises Boston Scientific outlook to negative on franchise pressures
NeutralNov 6S&P revises Boston Scientific outlook to negative on franchise pressures
Leans bearishNov 6Edwards Lifesciences (EW) Could Be 21% Undervalued After Earnings Guidance And Trial Data
NeutralNov 6HCA Healthcare benefits: Caring for those who care for others
Leans bullishNov 6GE HealthCare invests in AI-powered cath lab robotics
Leans bullishNov 6Medtronic Makes Ninth CIIE Appearance With Over 120 Products, China Phase III Fund in Preparation
BullishNov 6Insiders Give Up US$41k As Anteris Technologies Global Stock Drops To US$5.58
NeutralNov 6Medtronic (NYSE:MDT): A Dividend Quality Play for Income Investors
Leans bullishNov 6
